Savita Dandapani, MD, PhD, discusses the rationale behind a study evaluating the combination of radium-223, hormone therapy, and SBRT in metastatic castration-sensitive prostate cancer.

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

San Luis Obispo County residents responded to a survey sent by The Tribune about difficulties accessing primary care here in ...

Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...